SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...

SPIRIVA RESPIMAT, 2.5 mcg, is a long-term, once-daily, prescription maintenance medicine used to control symptoms of chronic obstructive pulmonary disease (COPD) ...

Spiriva Respimat, as an add-on to inhaled corticosteroids or long-acting beta2 agonists, reduced the risk for severe asthma exacerbation in patients across severities of symptomatic asthma and a ...

Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray ...

SPIRIVA RESPIMAT, 1.25 mcg, is a long-term, once-daily, prescription maintenance treatment of asthma for people 6 years and older. SPIRIVA RESPIMAT is not a treatment for sudden asthma symptoms ...

Spiriva Respimat, a long-acting muscarinic antagonist (LAMA), is currently approved for use as maintenance treatment of asthma in patients aged ≥6 years.

As recently as March, Dutch researchers reported a nearly 30% increase in mortality with tiotropium Respimat, compared with tiotropium HandiHaler (Eur Respir J. 2013;42:606-615 ).

The FDA approved Spiriva Respimat for the long-term, once-daily treatment of asthma in patients aged 12 years and older, according to a manufacturer press release.“The [FDA] approval of Spiriva ...

Spiriva Respimat only comes as a brand-name drug. It’s not currently available in a generic version. A generic contains an exact copy of the active drug in a brand-name medication.

Philadelphia, Pennsylvania 21 st May, 2013 – In patients with symptomatic asthma despite at least ICS/LABA therapy, tiotropium delivered by the Respimat® SoftMist TM Inhaler increases time to ...

Spiriva Respimat contains the active ingredient tiotropium. Spiriva Respimat is used to make breathing easier for people with chronic obstructive pulmonary disease (COPD) and asthma.

SAN ANTONIO, Texas--(BUSINESS WIRE)--Tiotropium delivered once daily via Respimat™ significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic ...